369 related articles for article (PubMed ID: 24886653)
1. Analysis of rare variations reveals roles of amino acid residues in the N-terminal extracellular domain of nicotinic acetylcholine receptor (nAChR) alpha6 subunit in the functional expression of human alpha6*-nAChRs.
Dash B; Li MD
Mol Brain; 2014 May; 7():35. PubMed ID: 24886653
[TBL] [Abstract][Full Text] [Related]
2. Roles for N-terminal extracellular domains of nicotinic acetylcholine receptor (nAChR) β3 subunits in enhanced functional expression of mouse α6β2β3- and α6β4β3-nAChRs.
Dash B; Li MD; Lukas RJ
J Biol Chem; 2014 Oct; 289(41):28338-51. PubMed ID: 25028511
[TBL] [Abstract][Full Text] [Related]
3. Identification of N-terminal extracellular domain determinants in nicotinic acetylcholine receptor (nAChR) α6 subunits that influence effects of wild-type or mutant β3 subunits on function of α6β2*- or α6β4*-nAChR.
Dash B; Bhakta M; Chang Y; Lukas RJ
J Biol Chem; 2011 Nov; 286(44):37976-37989. PubMed ID: 21832048
[TBL] [Abstract][Full Text] [Related]
4. Modulation of gain-of-function α6*-nicotinic acetylcholine receptor by β3 subunits.
Dash B; Lukas RJ
J Biol Chem; 2012 Apr; 287(17):14259-69. PubMed ID: 22315221
[TBL] [Abstract][Full Text] [Related]
5. Two rare variations, D478N and D478E, that occur at the same amino acid residue in nicotinic acetylcholine receptor (nAChR) α2 subunit influence nAChR function.
Dash B; Li MD
Neuropharmacology; 2014 Oct; 85():471-81. PubMed ID: 24950454
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and functional comparisons of α6/α3β2β3-nAChRs and α4β2-nAChRs heterologously expressed in the human epithelial SH-EP1 cell line.
Chen DJ; Gao FF; Ma XK; Shi GG; Huang YB; Su QX; Sudweeks S; Gao M; Dharshaun T; Eaton JB; Chang YC; Mcintosh JM; Lukas RJ; Whiteaker P; Steffensen SC; Wu J
Acta Pharmacol Sin; 2018 Oct; 39(10):1571-1581. PubMed ID: 29795357
[TBL] [Abstract][Full Text] [Related]
7. Modulation of recombinant, α2*, α3* or α4*-nicotinic acetylcholine receptor (nAChR) function by nAChR β3 subunits.
Dash B; Bhakta M; Chang Y; Lukas RJ
J Neurochem; 2012 May; 121(3):349-61. PubMed ID: 22309577
[TBL] [Abstract][Full Text] [Related]
8. A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors.
Luo S; Zhangsun D; Schroeder CI; Zhu X; Hu Y; Wu Y; Weltzin MM; Eberhard S; Kaas Q; Craik DJ; McIntosh JM; Whiteaker P
FASEB J; 2014 Apr; 28(4):1842-53. PubMed ID: 24398291
[TBL] [Abstract][Full Text] [Related]
9. Biophysical and pharmacological characterization of α6-containing nicotinic acetylcholine receptors expressed in HEK293 cells.
Rasmussen AH; Strøbæk D; Dyhring T; Jensen ML; Peters D; Grunnet M; Timmermann DB; Ahring PK
Brain Res; 2014 Jan; 1542():1-11. PubMed ID: 24157862
[TBL] [Abstract][Full Text] [Related]
10. Discovery of an intrasubunit nicotinic acetylcholine receptor-binding site for the positive allosteric modulator Br-PBTC.
Norleans J; Wang J; Kuryatov A; Leffler A; Doebelin C; Kamenecka TM; Lindstrom J
J Biol Chem; 2019 Aug; 294(32):12132-12145. PubMed ID: 31221718
[TBL] [Abstract][Full Text] [Related]
11. The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.
Moretti M; Zoli M; George AA; Lukas RJ; Pistillo F; Maskos U; Whiteaker P; Gotti C
Mol Pharmacol; 2014 Sep; 86(3):306-17. PubMed ID: 25002271
[TBL] [Abstract][Full Text] [Related]
12. Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras.
Papke RL; Dwoskin LP; Crooks PA; Zheng G; Zhang Z; McIntosh JM; Stokes C
Neuropharmacology; 2008 Jun; 54(8):1189-200. PubMed ID: 18448138
[TBL] [Abstract][Full Text] [Related]
13. Reporter mutation studies show that nicotinic acetylcholine receptor (nAChR) α5 Subunits and/or variants modulate function of α6*-nAChR.
Dash B; Chang Y; Lukas RJ
J Biol Chem; 2011 Nov; 286(44):37905-37918. PubMed ID: 21873428
[TBL] [Abstract][Full Text] [Related]
14. A signal peptide missense mutation associated with nicotine dependence alters α2*-nicotinic acetylcholine receptor function.
Dash B; Lukas RJ; Li MD
Neuropharmacology; 2014 Apr; 79():715-25. PubMed ID: 24467848
[TBL] [Abstract][Full Text] [Related]
15. Contribution of valine 7' of TMD2 to gating of neuronal alpha3 receptor subtypes.
Nieves-Cintrón M; Caballero-Rivera D; Navedo MF; Lasalde-Dominicci JA
J Neurosci Res; 2006 Dec; 84(8):1778-88. PubMed ID: 17044037
[TBL] [Abstract][Full Text] [Related]
16. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator.
Hamouda AK; Deba F; Wang ZJ; Cohen JB
Mol Pharmacol; 2016 May; 89(5):575-84. PubMed ID: 26976945
[TBL] [Abstract][Full Text] [Related]
17. A role for α4(non-α6)* nicotinic acetylcholine receptors in motor behavior.
Soll LG; Grady SR; Salminen O; Marks MJ; Tapper AR
Neuropharmacology; 2013 Oct; 73():19-30. PubMed ID: 23688922
[TBL] [Abstract][Full Text] [Related]
18. Amino acids outside of the loops that define the agonist binding site are important for ligand binding to insect nicotinic acetylcholine receptors.
Liu Z; Han Z; Liu S; Zhang Y; Song F; Yao X; Gu J
J Neurochem; 2008 Jul; 106(1):224-30. PubMed ID: 18363827
[TBL] [Abstract][Full Text] [Related]
19. Rare human nicotinic acetylcholine receptor α4 subunit (CHRNA4) variants affect expression and function of high-affinity nicotinic acetylcholine receptors.
McClure-Begley TD; Papke RL; Stone KL; Stokes C; Levy AD; Gelernter J; Xie P; Lindstrom J; Picciotto MR
J Pharmacol Exp Ther; 2014 Mar; 348(3):410-20. PubMed ID: 24385388
[TBL] [Abstract][Full Text] [Related]
20. α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.
van Hout M; Valdes A; Christensen SB; Tran PT; Watkins M; Gajewiak J; Jensen AA; Olivera BM; McIntosh JM
Neuropharmacology; 2019 Oct; 157():107691. PubMed ID: 31255696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
